(Q38710511)

5 September 2017

1 reference

title

Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs (English)

1 reference

5 September 2017

1

Darwin J Prockop

1 reference

5 September 2017

Joo Youn Oh

2

1 reference

5 September 2017

Ryang Hwa Lee

series ordinal

3

1 reference

5 September 2017

publication date

21 June 2017

1 reference

5 September 2017

1 reference

5 September 2017

volume

25

1 reference

5 September 2017

issue

8

1 reference

5 September 2017

page(s)

1748-1756

1 reference

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells: immune evasive, not immune privileged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

The determination and interpretation of the therapeutic index in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Multilineage potential of adult human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Relearning the lessons of genomic stability of human cells during expansion in culture: implications for clinical research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Sarcoma derived from cultured mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem/stromal cells protect against autoimmunity via CCL2-dependent recruitment of myeloid-derived suppressor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Intravenous hMSCs Ameliorate Acute Pancreatitis in Mice via Secretion of Tumor Necrosis Factor-α Stimulated Gene/Protein 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mitochondrial transfer between cells can rescue aerobic respiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or Sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Suspension medium influences interaction of mesenchymal stromal cells with endothelium and pulmonary toxicity after transplantation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Stem cell transplantation: the lung barrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stromal cells and the innate immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Control of adaptive immunity by the innate immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stromal cells and hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells and adaptive immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells and immunomodulation: current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells and infectious diseases: Smarter than drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Secretion of immunoregulatory cytokines by mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

The Many Alternative Faces of Macrophage Activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Exploring the full spectrum of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Wormhole Travel for Macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

A relativity concept in mesenchymal stromal cell manufacturing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Strategies to improve the immunosuppressive properties of human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Comparative Efficacies of Long-Term Serial Transplantation of Syngeneic, Allogeneic, Xenogeneic, or CTLA4Ig-Overproducing Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Murine Systemic Lupus Erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human Adipose-Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Treatment of Collagen-Induced Arthritis Using Immune Modulatory Properties of Human Mesenchymal Stem Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells alleviate experimental rheumatoid arthritis through microRNA-regulated IκB expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal Stem Cells Induce Suppressive Macrophages Through Phagocytosis in a Mouse Model of Asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Restoration of Corneal Transparency by Mesenchymal Stem Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Comparison of bone marrow tissue- and adipose tissue-derived mesenchymal stem cells in the treatment of sepsis in a murine model of lipopolysaccharide-induced sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Protective effect of transplanted bone marrow-derived mesenchymal stem cells on pancreatitis-associated lung injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Mesenchymal stem cells as therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2017.06.004

Stromal stem cells: marrow-derived osteogenic precursors

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28647464

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28647464

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Multistage carcinogenesis in cell culture.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28647464

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2017.06.004

1 reference

5 September 2017

0 references

1 reference